Re-Evaluation of PD-1 Expression by T Cells as a Marker for Immune Exhaustion during SIV Infection

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hong, Jung Joo ^b   Amancha, Praveen K ^b   Rogers, Kenneth ^b   Ansari, Aftab A ^a   Villinger, Francois ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; FAS ANTIGEN; KI 67 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOSTIMULATION; MONONUCLEAR CELL; NONHUMAN; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T LYMPHOCYTE; UPREGULATION; VIREMIA; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; KI-67 ANTIGEN; MACACA MULATTA; PROGRAMMED CELL DEATH 1 RECEPTOR; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84875538870     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060186     Document Type: Article

References (41)

1. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology26: 677-704 10.1146/annurev.immunol.26.021607.090331.
2. Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, et al. (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. International Immunology 8: 765-772.
3. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature439: 682-687 10.1038/nature04444.
4. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature443: 350-354 10.1038/nature05115.
5. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, et al. (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. Journal of Virology81: 9249-9258 10.1128/JVI.00409-07.
6. Yao ZQ, King E, Prayther D, Yin D, Moorman J, (2007) T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunology20: 276-287 10.1089/vim.2006.0096.
7. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, et al. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. The New England Journal of Medicine366: 2443-2454 10.1056/NEJMoa1200690.
8. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine366: 2455-2465 10.1056/NEJMoa1200694.
9. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, et al. (2008) The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. Journal of Immunology (Baltimore, Md.: 1950)181: 6738-6746.
10. Salisch NC, Kaufmann DE, Awad AS, Reeves RK, Tighe DP, et al. (2010) Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1. Journal of Immunology (Baltimore, Md.: 1950)184: 476-487 10.4049/jimmunol.0902781; 10.4049/jimmunol.0902781.
11. Duraiswamy J, Ibegbu CC, Masopust D, Miller JD, Araki K, et al. (2011) Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. Journal of Immunology (Baltimore, Md.: 1950)186: 4200-4212 10.4049/jimmunol.1001783.
12. Sauce D, Almeida JR, Larsen M, Haro L, Autran B, et al. (2007) PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS(London, England) 21: 2005-2013 10.1097/QAD.0b013e3282eee548.
13. Vollbrecht T, Brackmann H, Henrich N, Roeling J, Seybold U, et al. (2010) Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection. Journal of Medical Virology82: 358-370 10.1002/jmv.21723.
14. Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, et al. (2009) The distribution and immune profile of T cell subsets in HIV-infected children from uganda. AIDSResearch and Human Retroviruses25: 65-71 10.1089/aid.2008.0138.
15. Rueda CM, Velilla PA, Chougnet CA, Montoya CJ, Rugeles MT, (2012) HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment. PloS One7: e30307 10.1371/journal.pone.0030307.
16. Nakanjako D, Ssewanyana I, Mayanja-Kizza H, Kiragga A, Colebunders R, et al. (2011) High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an african cohort. BMC Infectious Diseases 11: 43 10.1186/1471-2334-11-43.
17. Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F, (2012) Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. Journal of Immunology (Baltimore, Md.: 1950)188: 3247-3256 10.4049/jimmunol.1103138.
18. Kaizu M, Borchardt GJ, Glidden CE, Fisk DL, Loffredo JT, et al. (2007) Molecular typing of major histocompatibility complex class I alleles in the indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics59: 693-703 10.1007/s00251-007-0233-7.
19. Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, et al. (2009) Two MHC class I molecules associated with elite control of immunodeficiency virus replication, mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. Journal of Immunology (Baltimore, Md.: 1950) 182: 7763-7775 10.4049/jimmunol.0900111.
20. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, et al. (2001) Control of a mucosal challenge and prevention of AIDSby a multiprotein DNA/MVA vaccine. ScienceNew York, N.Y. 292: 69-74.
21. Veazey RS, Rosenzweig M, Shvetz DE, Pauley DR, DeMaria M, et al. (1997) Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clinical Immunology and Immunopathology 82: 230-242.
22. Onlamoon N, Rogers K, Mayne AE, Pattanapanyasat K, Mori K, et al. (2008) Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection. Immunology 124: 277-293.
23. Sumpter B, Dunham R, Gordon S, Engram J, Hennessy M, et al. (2007) Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: Implications for AIDSpathogenesis. Journal of Immunology (Baltimore, Md.: 1950)178: 1680-1691.
24. Gordon SN, Klatt NR, Bosinger SE, Brenchley JM, Milush JM, et al. (2007) Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. Journal of Immunology (Baltimore, Md.: 1950)179: 3026-3034.
25. Berhanu D, Mortari F, De Rosa SC, Roederer M, (2003) Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. Journal of Immunological Methods279: 199-207.
26. Wherry EJ, (2011) T cell exhaustion. NatureImmunology 12: 492-499.
27. Soares A, Govender L, Hughes J, Mavakla W, de Kock M, et al. (2010) Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. Journal of Immunological Methods362: 43-50 10.1016/j.jim.2010.08.007.
28. Shedlock DJ, Talbott KT, Morrow MP, Ferraro B, Hokey DA, et al. (2010) Ki-67 staining for determination of rhesus macaque T cell proliferative responses ex vivo. Cytometry.Part A: The Journal of the International Society for Analytical Cytology77: 275-284 10.1002/cyto.a.20857.
29. Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, et al. (2007) SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110: 928-936.
30. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, et al. (2002) Development and homeostasis of T cell memory in rhesus macaque. Journal of Immunology (Baltimore, Md.: 1950)168: 29-43.
31. Wong MM, Fish EN, (2003) Chemokines: Attractive mediators of the immune response. Seminars in Immunology 15: 5-14.
32. Jones KL, Maguire JJ, Davenport AP, (2011) Chemokine receptor CCR5: From AIDSto atherosclerosis. British Journal of Pharmacology 162: 1453-146910.1111/j.1476-5381.2010.01147.x;10.1111/j.1476-5381.2010.01147.x.
33. Forster R, Davalos-Misslitz AC, Rot A, (2008) CCR7 and its ligands: Balancing immunity and tolerance. NatureReviews.Immunology 8: 362-371 10.1038/nri2297.
34. Dyavar Shetty R, Velu V, Titanji K, Bosinger SE, Freeman GJ, et al. (2012) PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. The Journal of Clinical Investigation 122: 1712-1716.10.1172/JCI60612; 10.1172/JCI60612.
35. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature458: 206-210 10.1038/nature07662.
36. Hokey DA, Johnson FB, Smith J, Weber JL, Yan J, et al. (2008) Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. European Journal of Immunology 38: 1435-1445.
37. Tendeiro R, Foxall RB, Baptista AP, Pinto F, Soares RS, et al. (2012) PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia. AIDS(London,England). 10.1097/QAD.0b013e32835374db.
38. Terawaki S, Chikuma S, Shibayama S, Hayashi T, Yoshida T, et al. (2011) IFN-alpha directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. Journal of Immunology (Baltimore, Md.: 1950)186: 2772-277910.4049/jimmunol.1003208.
39. Centlivre M, Sala M, Wain-Hobson S, Berkhout B, (2007) In HIV-1 pathogenesis the die is cast during primary infection. AIDSLondon, England. 21: 1-11 10.1097/QAD.0b013e3280117f7f.
40. Doms RW, (2001) Chemokine receptors and HIV entry. AIDSLondon, England. 15Suppl 1: S34-5.
41. Sina ST, Ren W, Cheng-Mayer C, (2011) Coreceptor use in nonhuman primate models of HIV infection. Journal of Translational Medicine9Suppl 1: S7 10.1186/1479-5876-9-S1-S7.